
Professor Borge Nordestgaard
Copenhagen University Hospital, Copenhagen (Denmark)
Biography
Prof. Nordestgaard has studied and worked in Copenhagen, New York, and London. He has for more than 40 years continued his interest in the pathogenesis, diagnosis and treatment of familial hypercholesterolemia, hyperlipidemia, atherosclerosis and cardiovascular disease, and has written extensively on these conditions.
He is chairing the Copenhagen General Population Study and is also a steering committee member of the Copenhagen City Heart Study and of several randomised intervention trials.
Prof. Børge G. Nordestgaard has supervised 75 Ph.D. students and 36 postdoctoral fellows, and has published >1050 original articles and >180 reviews, book chapters, consensus statements, & editorials. His H-index is 188 and he has published >100 highly cited papers.
Original articles include publications in New England J Med, Lancet, Nature, Science, Nature Genetics, JAMA, British Medical Journal, Ann Intern Med, Eur Heart J, Circulation and JACC.
Contributor content
Session
Everything you wanted to know about lipoprotein(a)
30 August 2026
Session
From risk to responsibility: responding to the cardiovascular epidemic through a multi-stakeholder dialogue integrating patient voices
30 August 2026
Session
Cardiovascular epidemic: tackling low-density lipoprotein driven cardiovascular risk
30 August 2026
Session
From guidelines to action - Debating real-world and future approaches to low-density lipoprotein cholesterol management
29 August 2026
Session
Reimagining low-density lipoprotein cholesterol management, driving meaningful action - LDL-C Action Lab
29 August 2026
Session
The cardiovascular epidemic: delivering on European Union Safe Hearts and national action plans
29 August 2026
Session
Lipids over the life course: how to manage
29 August 2026
Session
Late-Breaking Clinical Science: lipids and cardiovascular risk
1 September 2025
Session
Ask the Trialists - Essence-TIMI 73b
31 August 2025
Session
Modifying lipids to decrease cardiovascular risk
26 August 2023


